Do you want to read an article? Please log in or register.
SMOKING STATUS AND TREATMENT OUTCOMES OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Macular Diseases
Related content
COMMENTED
Macular DiseasesRetinal Diseases
INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Retina.
Vazquez-Alfageme C, Nicholson L, Hamilton RD, Patel PJ
doi: 10.1097/IAE.
Macular Diseases
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19
Ophthalmol Retina.
Keenan TD, Vitale S, Agrón E, Domalpally A, Antoszyk AN, Elman MJ, Clemons TE, Chew EY, Age-Related Eye Disease Study 2 Research Group.
doi: 10.1016/j.oret.2019.06.001.
Macular Diseases
Four-week outcomes of vascular endothelial growth factor inhibitors for neovascular age related macular degeneration
Clin Exp Ophthalmol.
Wiryasaputra S, Nguyen V, Arnold JJ, Ferrier R, Hinchcliffe P, Barthelmes D, Gillies MC
doi: 10.1111/ceo.13798.
Macular Diseases
Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol.
Stem MS, Moinuddin O, Kline N, Thanos A, Rao P, Williams GA, Hassan TS
Macular Diseases
Age-related macular degeneration-associated peripapillary choroidal neovascularization in the era of anti-vascular endothelial growth factor therapy
Retina.
Lin T, Dans K, Meshi A, Muftuoglu IK, Amador-Patarroyo MJ, Chen KC, Cheng L, Freeman WR
doi: 10.1097/IAE.
COMMENTED
Macular Diseases
Lifetime Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
JAMA Ophthalmol
Finger RP, Puth MT, Schmid M, Barthelmes D, Guymer RH, Gillies M
doi: 10.1001/jamaophthalmol.2020.3989
Macular Diseases
Characterisation of poor visual outcomes of neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents
Ophthalmology.
Nguyen CL, Gillies MC, Nguyen V, Daien V, Cohn A, Banerjee G, Arnold J; Fight Retinal Blindness! Study Group
doi: 10.1016/j.ophtha.2018.11.036.
COMMENTED
Macular Diseases
Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
★ 2
Recommended and commented by
Prof. Dr Stephan Michels, Faculty Member
BMC Ophthalmol.
Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, Sakamoto T, Wong TY, Pantiri K, Carrasco J
doi: 10.1186/s12886-020-01554-2.
Macular Diseases
Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
JAMA Ophthalmol.
Subhi Y, Krogh Nielsen M, Molbech CR, Krüger Falk M, Singh A, Hviid TVF, Nissen MH, Sørensen TL
doi: 10.1001/jamaophthalmol.